Christopher Rovaldi

Affiliations

  • Chief Operating Officer at Keros Therapeutics Inc. (KROS), 2025-02-19
  • Svp, Program Mgmt And Ops at Acceleron Pharma Inc (XLRN), 2018-04-04
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
KROS $65.00 1,728 $112,320.00 0 2022-04-06 Filing
KROS $58.83 105 $6,177.15 0 2022-04-01 Filing
KROS $57.97 366 $21,217.02 105 2022-04-01 Filing
KROS $56.89 287 $16,327.43 471 2022-04-01 Filing
KROS $56.20 104 $5,844.80 758 2022-04-01 Filing